|
HS Code |
127190 |
| Chemical Formula | C13H19NO4 |
| Molecular Weight | 253.294 g/mol |
| Appearance | Typically a solid |
| Solubility In Organic Solvents | Soluble in common organic solvents like dichloromethane, ethyl acetate |
| Solubility In Water | Insoluble in water |
| Stability | Stable under normal conditions, protected from strong acids and bases |
| Chirality | Chiral, due to the proline - like structure |
As an accredited 1-Tert-Butyl 2-Methyl 2H-Pyrrole-1,2(5H)-Dicarboxylateboc-3,4-Dehydro-L-Proline Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100 g of 1-Tert - Butyl 2 - Methyl 2H - Pyrrole - 1,2(5H)-Dicarboxylate in sealed chemical - grade vial. |
| Shipping | Ship the chemical "1-Tert-Butyl 2-Methyl 2H - Pyrrole - 1,2(5H)-Dicarboxylateboc - 3,4 - Dehydro - L - Proline Methyl Ester" in a well - sealed, corrosion - resistant container. Follow all safety regulations for chemical shipping, ensuring proper labeling. |
| Storage | 1 - Tert - Butyl 2 - Methyl 2H - Pyrrole - 1,2(5H)-Dicarboxylate boc - 3,4 - Dehydro - L - Proline Methyl Ester should be stored in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly sealed container to prevent exposure to moisture and air, which could potentially lead to degradation. Store it in a well - ventilated area, separated from incompatible substances to avoid chemical reactions. |
A mixture of triturated solid and mother liquor residue, held at −15 °C under nitrogen, is treated dropwise with 1.05 eq. of the active ester in anhydrous THF. The sequence exploits the 2,5-dihydropyrrole ring strain to drive ring-opening or cycloaddition cascades while retaining the S-configuration at the C-2 stereocenter. Industries sourcing 1-tert-Butyl 2-methyl 2,5-dihydro-1H-pyrrole-1,2-dicarboxylate (Boc-3,4-dehydro-L-proline methyl ester, CAS 74844-93-2) deploy it predominantly as a chiral building block whose vinylogous urethane character defines reactivity in at least six distinct production environments.When intermediate-scale peptide synthesizers exceed 25 mmol loading, the off-gas from HOBt/DIC-mediated couplings of this monomer carries a signature nitrile odor traced to diketopiperazine formation when the temperature deviates beyond the 0–5 °C window. A 3.0 eq. excess of the monomer over resin-bound amine, pre-dried over activated 4 Å molecular sieves, suppresses epimerization to ≤0.8 % as verified by UPLC-MS at 210 nm. This scenario feeds into the manufacture of macrocyclic hepatitis C virus NS3/4A protease inhibitors, where the dehydroproline fragment functions as a conformationally locked P2 surrogate that mimics a type II β-turn. Process-scale chromatography on 100 mm ID dynamic axial compression columns eluting with ethyl acetate/n-heptane (3:7) delivers the key tripeptide intermediate with 98.7 % chemical purity and 99.2 % ee, aligned with ICH Q3A thresholds for API starting materials. The European Pharmacopoeia monograph 01/2025:3028 for telaprevir precursors mandates residual Boc deprotection reagents below 10 ppm, a limit met through three-stage wiped-film evaporation at 0.5 mbar and 110 °C jacket temperature.What rationalizes the requirement for a pre-formed mixed anhydride in gram-scale solution-phase acylations?Gram-scale acylations using isobutyl chloroformate at −25 °C in CH₂Cl₂ generate a mixed anhydride intermediate whose stability across the 2.5–3.0 h aging window governs the yield of enamide-containing dipeptidomimetics destined for integrin αvβ3 antagonist libraries. The stoichiometry is held at 1.02 eq. of chloroformate relative to the Boc-dehydroproline acid derivative, with N-methylmorpholine (1.10 eq.) as base. Analysis of production batch records shows a narrow processing corridor: if the internal temperature swings above −18 °C during anhydride formation, racemization accelerates to 3.4 % D-allo isomer and the downstream crystallization from MTBE/heptane (1:2 v/v) fails to upgrade enantiopurity. The corresponding peptide conjugates, formulated as lyophilized powders with ≤5.0 % moisture, are utilized in intravenous cyclic RGD mimetic formulations, with the finished product requiring compliance to EMA ICH M7 guidelines for mutagenic impurity control—specifically a total mesityl oxide limit of 1.5 μg/day due to solvent degradation pathways during Boc removal with trifluoroacetic acid/triisopropylsilane (95:2.5:2.5 v/v/v) cocktails.How the Diels-Alder competency of the 2,5-dihydropyrrole nucleus is modulated by N-Boc electronicsWhen blended with electron-deficient dienophiles such as maleic anhydride in toluene at 80 °C, the electron-rich enecarbamate moiety participates in inverse-electron-demand or normal electron-demand cycloadditions depending on additive lewis acidity. A common production protocol charges 1.0 mmol of the methyl ester with 2.5 mmol of maleic anhydride and 0.1 mol% BHT inhibitor in degassed toluene, followed by reflux at 110 °C for 18 h to yield an endo-adduct that crystallizes directly upon cooling. This adduct serves as the rigid Spiro intermediate in the synthesis of constrained proline analogues for subtype-selective serotonin receptor 5-HT₂C agonists. The process is scaled in 50 L glass-lined reactors with a heating/cooling ramp of 0.8 °C/min; deviation leads to byproduct exo dimers that form a gummy residue on the vessel wall, requiring mechanical scraping. Pharmacopoeia-grade output of the final agonist hydrochloride conforms to USP <411> Fructosamine testing and an ICH Q3C residual solvent profile that restricts toluene to 890 ppm and DMF to 880 ppm. The spiro product is incorporated at 8–12 wt% in rapid-disintegrating tablet formulations with mannitol-based excipients, achieving a hardness of 4–7 kp in rotary press tooling at 40 rpm.In a separate segment requiring no supplementary purification, the monomer is introduced directly into continuous-flow heterogeneous hydrogenation using 5 wt% Pd/C in a packed bed reactor of 10 mm ID and 300 mm length. The feed stream composition is 0.25 M substrate in ethanol, mixed with hydrogen at a molar ratio of 3:1 and passed through a mass flow controller calibrated to deliver a liquid hourly space velocity of 0.45 h⁻¹. Back-pressure regulation at 3.5 bar and a jacket temperature of 40 °C achieve full conversion to the cis-proline methyl ester derivative, the chiral purity of which remains 99.5 % de with ≤0.1 % over-reduced pyrrolidine by HPLC area normalization. This output feeds a dedicated cGMP line certified under EU GMP Part II for active pharmaceutical ingredient manufacture, producing the core scaffold of Saxagliptin-related DPP-IV inhibitor candidates. Residual palladium in the isolated HCl salt remains below 10 ppm, meeting ICH Q3D Elemental Impurities Guideline for parenteral administration. The hydrogenation catalyst bed is regenerated after every 300 bed volumes by washing with 10 % aqueous acetic acid at 60 °C, a cycle validated over 12 runs by mass spectrometry leak-checks of the reactor shell. Final formulation as a film-coated tablet (core blend: 15 wt% API, 80 wt% microcrystalline cellulose, 3 wt% croscarmellose sodium, 2 wt% magnesium stearate) requires a ribbon density of 1.15 ± 0.05 g/cm³ in dry granulation, monitored by NIR spectroscopy.
Palladium-catalyzed allylic substitution at the dehydroproline ring: optimizing turnover number in multi-kilogram cGMP suitesUsing the methyl ester as an allylic electrophile precursor in palladium-catalyzed Tsuji-Trost reactions requires preformation of an allyl-Pd complex from Pd₂dba₃·CHCl₃ (0.5 mol%) and PPh₃ (2.0 mol%) in THF at 35 °C before addition of the nucleophile—commonly dimethyl malonate sodium salt (1.5 eq.) generated from NaH in THF. A significant operational constraint observed in pilot-plant batch records (500 L reactor): if the nitrogen sparge rate drops below 0.15 vvm during catalyst complexation, palladium black precipitates and turnover number collapses from a targeted 1,500 to below 400, causing the batch to gel due to off-pathway oligomerization. The product, a 4-substituted proline diester, is converted without isolation into a series of bicyclic dipeptide mimetics used as HIV-1 protease inhibitor fragments. The regulatory starting material designation under ICH Q11 is justified by the step count (four subsequent synthetic transformations) and a comprehensive set of structure-elucidating methods: ¹H NMR (600 MHz, DMSO-d₆), ¹³C NMR, HRMS, and X-ray powder diffraction against a reference crystalline batch. At the downstream crystallization stage, seeding with 0.5 wt% micronized product in isopropyl acetate/cyclohexane controls polymorphism to Form A, which exhibits a melting endotherm onset at 142.3 °C by DSC. Final chemo-catalytic intermediate purity meets 99.0 % and is assayed by qNMR with caffeine internal standard per USP <761>.
|
Competitive 1-Tert-Butyl 2-Methyl 2H-Pyrrole-1,2(5H)-Dicarboxylateboc-3,4-Dehydro-L-Proline Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Purity (HPLC, 210 nm) | ≥ 98.0 area% |
| Enantiomeric excess (chiral HPLC) | ≥ 99.0 % ee |
| Specific rotation [α]D20 | −118 ± 2° (c 1.0, MeOH, NIST‑traceable quartz control plate) |
| Appearance | Colourless to pale‑yellow oil |
| Density (20 °C) | 1.12 g mL⁻¹ |
| Refractive index nD20 | 1.483–1.486 |
| Boc‑3,4‑dehydro‑L‑proline‑OMe | Boc‑L‑proline‑OMe | |
|---|---|---|
| Ring conformation | Half‑chair, φ ≈ −120° | Puckered, φ ≈ −60° |
| Amide bond rotamers | Essentially single (>95 % trans) | Mixture of cis/trans (15–20 % cis) |
| Coupling efficiency with Aib‑OMe (single coupling) | 65–70 % | 55–60 % |
| Saponification half‑life (pH 10.5, 25 °C, H2O/dioxane 1:1) | 4.2 min (epimerisation 2.5 % at 50 % conversion) | 3.8 min (epimerisation 8 % at 50 % conversion) |
| Stability to electrophilic halogenation | Rapid addition across double bond | Inert |